Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;67(1):107-11.
doi: 10.1001/archneurol.2009.311.

Lost in translation: epidemiology, risk, and Alzheimer disease

Affiliations

Lost in translation: epidemiology, risk, and Alzheimer disease

Mary Ganguli et al. Arch Neurol. 2010 Jan.

Abstract

There is increasing emphasis on interdisciplinary “translation” in biomedical research. A major push towards prevention of Alzheimer's Disease is spawning translational research that should span basic, clinical, and population investigations. Epidemiological studies, which address our understanding of risk and protective factors for disease at the population level, are contributing less than they could to translational research. In part, this is because the key concept of risk is being “lost in translation,” muddling interpretations and leading to interdisciplinary frustrations. Two epidemiologists offer a framework for resolving some of the confusion.

PubMed Disclaimer

References

    1. Zerhouni E. Translational and clinical science – time for a new vision. N. Engl. J. Med. 2005;353:1621–1623. - PubMed
    1. Hodes RJ. Public funding for Alzheimer disease research in the United States. Nature Medicine. 2006;12:770–773. - PubMed
    1. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women. JAMA. 2002;288:2123–2129. - PubMed
    1. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. Women's Health Initiative Memory Study. JAMA. 2004;291:2947–2958. - PubMed
    1. ADAPT Research Group Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology. 2007;68:1800–1808. - PubMed

Publication types

MeSH terms